Skip to content

Clinical trials

Retinoblastoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinoblastoma Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20133
20161
20202
20213
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Recruiting5
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University7
Eye & ENT Hospital of Fudan University3
Beijing Tongren Hospital1
Chengdu Kanghong Biotech Co., Ltd.1
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinoblastoma13
Hepatoblastoma1
Leukemia, Myeloid, Acute1
Lymphoma1
Neuroblastoma1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Recurrence1
Wounds and Injuries1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.